Actively Recruiting
A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds
Led by Samyang Biopharmaceuticals Corporation · Updated on 2026-03-05
30
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective clinical investigation designed to evaluate the performance and safety of DMFI150 for the treatment of nasolabial folds. 30 adult participants will receive a single treatment with the investigational device. The study will assess wrinkle severity using validated aesthetic evaluation scales, as well as overall safety.
CONDITIONS
Official Title
A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women aged 18-70 years
- Score of 3 to 4 on the Wrinkle Severity Rating Scale for both nasolabial folds
- Able and willing to provide written informed consent
- Willing to refrain from facial cosmetic procedures during the study
You will not qualify if you...
- Use of antiplatelet agents, vitamin E, or NSAIDs within 2 weeks before screening or 2 weeks after treatment
- History or current bleeding disorders
- Participation in another clinical trial within 1 month before screening
- Pregnant or breastfeeding women, or planning pregnancy
- Women of childbearing potential not using effective contraception
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ocean Clinic
Marbella, Spain
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here